Inhibitors of arginase and their therapeutic applications

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10538537
APP PUB NO 20180251479A1
SERIAL NO

15972996

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds according to Formula I and Formula II are potent inhibitors of Arginase I and II activity:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MARS INCORPORATED6885 ELM STREET MCLEAN VA 22101-3883

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beckett, Raymond P McLean, US 3 7
Golebiowski, Adam McLean, US 31 164
Ji, Min K McLean, US 1 6
Ryder, Todd McLean, US 5 73
Van, Zandt Michael Guilford, US 28 263
Whitehouse, Darren Westbrook, US 28 356

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 21, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 21, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00